Efficacy of Mesna for Prevention of Hemorrhagic Cystitis After High-Dose Cyclophosphamide Therapy-Reference-Cited by-同舟云学术

Efficacy of Mesna for Prevention of Hemorrhagic Cystitis After High-Dose Cyclophosphamide Therapy

Published:1995-09 Issue:9 Volume:29 Page:918-921
ISSN:1060-0280
Container-title:Annals of Pharmacotherapy
language:en
Short-container-title:Ann Pharmacother

Author:

Haselberger Mary Beth¹,Schwinghammer Terry L²

Affiliation:

1. Resident in Geriatrics, Veterans Affairs Medical Center, Cleveland. OH

2. Bone Marrow Transplantation, University of Pittsburgh Medical Center, and Associate Professor of Pharmacy and Therapeutics, University of Pittsburgh School of Pharmacy

Publisher

SAGE Publications

Subject

Pharmacology (medical)

Link

http://journals.sagepub.com/doi/pdf/10.1177/106002809502900914

Reference21 articles.

1. Association of BK Viruria with Hemorrhagic Cystitis in Recipients of Bone Marrow Transplants

2. Hemorrhagic Cystitis: A Review

Cited by 61 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Initiation of Haploidentical Stem Cell Transplantation With Post‐Transplant Cyclophosphamide in Children: A Low–Middle‐Income Country Institutional Experience;Pediatric Transplantation;2024-08-19

2. Ferroptosis contributes to cyclophosphamide-induced hemorrhagic cystitis;Chemico-Biological Interactions;2023-10

3. MESNA HAS ANTIOXIDANT POTENTIAL ON INTESTINE REMOTE ORGAN INJURY INDUCED BY INTESTINAL ISCHEMIA/ REPERFUSION;Trakya University Journal of Natural Sciences;2022-10-03

4. A Clinical Review of the Different Strategies to Minimize Hemorrhagic Cystitis Associated with the Use of Post-Transplantation Cyclophosphamide in an Allogeneic Transplant;Transplantation and Cellular Therapy;2022-07

5. Long-term survival with mixed chimerism in patients with AML and MDS transplanted after conditioning with targeted busulfan, fludarabine, and thymoglobulin;Bone Marrow Transplantation;2021-11-05